In his new book "Curved Air", Kevin Davies, PhD, portrays the fascinating story of sickle cell disease, from its origins in ...

Eli Lilly has presented early positive clinical data supporting once-weekly dosing for its GIP/GLP-1 receptor agonist candidate brenipatide in substance use, psychiatric, and immunologic disorders—and ...

Del-desiran was one of three clinical setbacks for Novartis within a week. On 4, Novartis and Ionis Pharmaceuticals ...

In kidney organoids, elevated glucose triggered tissue-intrinsic inflammation and epithelial cell detachment without overt cytotoxicity. Inhibiting MIF, TNF-alpha, or MAPK-related signaling helped ...

Study identified age-related HGG patient groups that demonstrated distinct molecular profiles and survival outcomes, and were ...

A new genome-editing method, prime assembly, precisely inserts long DNA sequences into targeted genomic locations.

Discovery could open up new avenues for studying diseases that affect the brainstem, such as spinal muscular atrophy and amyotrophic lateral sclerosis.

Findings provide some of the strongest human evidence to date that expansion of the Huntington mutation is a key factor in ...

A majority of biopharmas are expected to increase their reliance on CDMOs in coming years despite rising costs for their ...

A 12-week pilot study found time-restricted eating was safe and feasible for people with early Huntington’s disease.

Researchers at Virginia Tech have developed a prophylactic phage therapy approach to protecting against potential future ...

The company has plans to launch an early access program this month to test-drive the second-generation of its AI platform.